- Home
- Publications
- Publication Search
- Publication Details
Title
Intravesical therapy for bladder cancer
Authors
Keywords
-
Journal
EXPERT OPINION ON PHARMACOTHERAPY
Volume 16, Issue 6, Pages 889-901
Publisher
Informa Healthcare
Online
2015-03-14
DOI
10.1517/14656566.2015.1024656
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Combined Chemohyperthermia: 10-Year Single Center Experience in 160 Patients with Nonmuscle Invasive Bladder Cancer
- (2014) Tom J.H. Arends et al. JOURNAL OF UROLOGY
- The mechanism of action of BCG therapy for bladder cancer—a current perspective
- (2014) Gil Redelman-Sidi et al. Nature Reviews Urology
- Maintenance Bacillus Calmette-Guérin Treatment of Non–muscle-invasive Bladder Cancer: A Critical Evaluation of the Evidence
- (2013) Behfar Ehdaie et al. EUROPEAN UROLOGY
- EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013
- (2013) Marko Babjuk et al. EUROPEAN UROLOGY
- Side Effects of Bacillus Calmette-Guérin (BCG) in the Treatment of Intermediate- and High-risk Ta, T1 Papillary Carcinoma of the Bladder: Results of the EORTC Genito-Urinary Cancers Group Randomised Phase 3 Study Comparing One-third Dose with Full Dose and 1 Year with 3 Years of Maintenance BCG
- (2013) Maurizio Brausi et al. EUROPEAN UROLOGY
- SWOG S0353: Phase II Trial of Intravesical Gemcitabine in Patients with Nonmuscle Invasive Bladder Cancer and Recurrence after 2 Prior Courses of Intravesical Bacillus Calmette-Guérin
- (2013) Eila C. Skinner et al. JOURNAL OF UROLOGY
- A Randomized, Controlled Clinical Trial of a Novel Intravesical Pressure Attenuation Device for the Treatment of Stress Urinary Incontinence
- (2013) Eric S. Rovner et al. JOURNAL OF UROLOGY
- Defining Progression in Nonmuscle Invasive Bladder Cancer: It is Time for a New, Standard Definition
- (2013) Donald Lamm et al. JOURNAL OF UROLOGY
- Combination of a fusogenic glycoprotein, pro-drug activation and oncolytic HSV as an intravesical therapy for superficial bladder cancer
- (2012) G R Simpson et al. BRITISH JOURNAL OF CANCER
- A Contemporary Update on Pathology Standards for Bladder Cancer: Transurethral Resection and Radical Cystectomy Specimens
- (2012) Donna E. Hansel et al. EUROPEAN UROLOGY
- Final Results of an EORTC-GU Cancers Group Randomized Study of Maintenance Bacillus Calmette-Guérin in Intermediate- and High-risk Ta, T1 Papillary Carcinoma of the Urinary Bladder: One-third Dose Versus Full Dose and 1 Year Versus 3 Years of Maintenance
- (2012) Jorg Oddens et al. EUROPEAN UROLOGY
- Changes in use of long-acting contraceptive methods in the United States, 2007–2009
- (2012) Lawrence B. Finer et al. FERTILITY AND STERILITY
- A First in Human Phase 1 Study of CG0070, a GM-CSF Expressing Oncolytic Adenovirus, for the Treatment of Nonmuscle Invasive Bladder Cancer
- (2012) James M. Burke et al. JOURNAL OF UROLOGY
- Continuous Intravesical Lidocaine Treatment for Interstitial Cystitis/Bladder Pain Syndrome: Safety and Efficacy of a New Drug Delivery Device
- (2012) J. C. Nickel et al. Science Translational Medicine
- Female Gender and Carcinoma In Situ in the Prostatic Urethra Are Prognostic Factors for Recurrence, Progression, and Disease-Specific Mortality in T1G3 Bladder Cancer Patients Treated With Bacillus Calmette-Guérin
- (2011) Joan Palou et al. EUROPEAN UROLOGY
- A Review of Current Guidelines and Best Practice Recommendations for the Management of Nonmuscle Invasive Bladder Cancer by the International Bladder Cancer Group
- (2011) Maurizio Brausi et al. JOURNAL OF UROLOGY
- Gemcitabine versus bacille Calmette-Guérin after initial bacille Calmette-Guérin failure in non-muscle-invasive bladder cancer
- (2010) Giuseppe Di Lorenzo et al. CANCER
- Hexaminolevulinate Guided Fluorescence Cystoscopy Reduces Recurrence in Patients With Nonmuscle Invasive Bladder Cancer
- (2010) Arnulf Stenzl et al. JOURNAL OF UROLOGY
- Bacillus Calmette-Guérin With or Without Interferon α-2b and Megadose Versus Recommended Daily Allowance Vitamins During Induction and Maintenance Intravesical Treatment of Nonmuscle Invasive Bladder Cancer
- (2010) Kenneth G. Nepple et al. JOURNAL OF UROLOGY
- The Role of Pathology Review of Transurethral Bladder Tumor Resection Specimens in the Modern Era
- (2010) Michael C. Lee et al. JOURNAL OF UROLOGY
- Long-term Efficacy of Maintenance Bacillus Calmette-Guérin versus Maintenance Mitomycin C Instillation Therapy in Frequently Recurrent TaT1 Tumours without Carcinoma In Situ: A Subgroup Analysis of the Prospective, Randomised FinnBladder I Study with a 20-Year Follow-up
- (2009) Riikka Järvinen et al. EUROPEAN UROLOGY
- Should All Patients with Non–Muscle-Invasive Bladder Cancer Receive Early Intravesical Chemotherapy after Transurethral Resection? The Results of a Prospective Randomised Multicentre Study
- (2009) Sigurdur Gudjónsson et al. EUROPEAN UROLOGY
- An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Guérin for Non–Muscle-Invasive Bladder Cancer
- (2009) Per-Uno Malmström et al. EUROPEAN UROLOGY
- Photodynamic Diagnosis in Non–Muscle-Invasive Bladder Cancer: A Systematic Review and Cumulative Analysis of Prospective Studies
- (2009) Ingo Kausch et al. EUROPEAN UROLOGY
- Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guérin, and Bacillus Calmette-Guérin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder
- (2009) Richard J. Sylvester et al. EUROPEAN UROLOGY
- Detrusor Muscle in the First, Apparently Complete Transurethral Resection of Bladder Tumour Specimen Is a Surrogate Marker of Resection Quality, Predicts Risk of Early Recurrence, and Is Dependent on Operator Experience
- (2009) Paramananthan Mariappan et al. EUROPEAN UROLOGY
- Definition and management of patients with bladder cancer who fail BCG therapy
- (2009) Frances M Martin et al. Expert Review of Anticancer Therapy
- Randomized Phase III Trial on Gemcitabine Versus Mytomicin in Recurrent Superficial Bladder Cancer: Evaluation of Efficacy and Tolerance
- (2009) Raffaele Addeo et al. JOURNAL OF CLINICAL ONCOLOGY
- The Schedule and Duration of Intravesical Chemotherapy in Patients with Non–Muscle-Invasive Bladder Cancer: A Systematic Review of the Published Results of Randomized Clinical Trials
- (2008) Richard J. Sylvester et al. EUROPEAN UROLOGY
- Clinical Practice Recommendations for the Prevention and Management of Intravesical Therapy–Associated Adverse Events
- (2008) J. Alfred Witjes et al. EUROPEAN UROLOGY SUPPLEMENTS
- Prognostic Factors in Patients with Non–Muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin: Multivariate Analysis of Data from Four Randomized CUETO Trials
- (2007) Jesus Fernandez-Gomez et al. EUROPEAN UROLOGY
- A Single Instillation of Epirubicin After Transurethral Resection of Bladder Tumors Prevents Only Small Recurrences
- (2007) Ingela Berrum-Svennung et al. JOURNAL OF UROLOGY
- History of Bacillus Calmette-Guerin and Bladder Cancer: An Immunotherapy Success Story
- (2007) Harry W. Herr et al. JOURNAL OF UROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More